NOVIGENIX AI (NOVIGENIX SA)
Company Snapshot
Company Overview
Novigenix is a Swiss-based precision medicine company specializing in Immuno-transcriptomic solutions aimed at early disease detection, the development of therapeutics, and drug target discovery.
The company’s proprietary LITOSeek platform is an AI-driven RNA analysis tool designed to track the immune system's response to disease onset and progression. By integrating multi-omics patient data with advanced machine learning and AI techniques, Novigenix offers actionable insights and precision solutions. Their liquid biopsy products and services cater to the biopharma sector, focusing on the clinical development of new therapies, drug target identification, and early colorectal cancer detection.
Novigenix serves pharmaceutical and biotechnology clients by utilizing the LITOSeek platform to analyze patient clinical data, revealing critical insights into patient response heterogeneity and enabling the development of actionable biomarkers for optimizing novel therapeutic strategies.
NOVIGENIX AI (NOVIGENIX SA) In News
Company's Business Segments
- Products : Immuno Transcriptomics, LITOseek platform, Others
- Services : Prevention through early detection of cancer, Precision Medicine, Innovative Drug Target Discovery
Applications/End User Industries
- Healthcare
- Pharmaceutical
- Biotechnology
- Research Institution
- Life Sciences